Seeking Alpha

NBIX
Neurocrine Biosciences, Inc.

5/26/2012, 5:07 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
NBIX Market Currents more »
  • May 2 Neurocrine Biosciences (NBIX): Q1 EPS of -$0.01 misses by $0.01. Revenue of $11.3M (-9.6% Y/Y) beats by $0.5M. Shares +0.5% AH. (PR)
    Comment!
    [Earnings, Healthcare]
NBIX in Focus more »
NBIX Instablog posts more »
  • Aerocrine AB Treating Inflammatory Airway Diseases
    Thu, Apr 12 • V.I.P. • Comment!
  • Magic Formula Investing Weekly Roundup 11/6/2011
    Sun, Nov 6, 2011 • MagicDiligence • Comment!
  • Competitive Technologies (CTTC) to be on Good Morning America Tomorrow
    Mon, Mar 14, 2011 • David Greene • 1 Comment
  • Elagolix - A Billion Dollar Drug
    Wed, Feb 23, 2011 • Jason Napodano • 4 Comments
  • Neurocrine Biosciences’ (NBIX) VMAT2 Program to Move Into Phase II Clinical Trials
    Tue, Oct 19, 2010 • QualityStocks • Comment!
Write a post on NBIX
NBIX StockTalks
NBIX vs. ETF Alternatives
Company Description
Currently, there's no company description for NBIX.
Sector: Healthcare
Industry: Biotechnology
Country: United States